Reviews / Übersichten

1 2 3

  • 31) Belz GG. Elastic properties and Windkessel function of the human aorta. Cardiovasc Drugs Ther 1995; 9:73-83. (Original-Artikel; PDF)
  • 32) Schroeter V, Belz GG. Kardiale Aspekte der klinischen Anwendung von H1-Rezeptorantagonisten. Münch Med Wochenschr 1997; 139:550-553.
  • 33) Lehmann ED, Belz GG. A role for aortic biophysical measurements in vivo. J Noninvasiv Cardiol 1998; 3:19-22.
  • 34) Breithaupt-Grögler K, Belz GG. Epidemiology of the arterial stiffness. Path Biol 1999; 47:604-613.
  • 35) Unger T, Azizi M, Belz GG. Blocking the tissue renin-angiotensin system: the future cornerstone of therapy. J Hum Hypertension 2000; 14(Suppl.2):S23-S31.
  • 36) Belz GG., Man in't Veld AJ. Differences among angiotensin II receptor antagonists: choosing the optimal agent in clinical practice. Eur Heart J Supplements 2000; 2 (Suppl.B):B8-B12.
  • 37) Belz GG., Breithaupt-Grögler K, Osowski U. Treatment of congestive heart failure – current status of use of digitoxin. Eur J Clin Invest 2001; 31(Suppl.2):10-17.
  • 38) Belz GG., Loew D. Dose-response related efficacy in orthostatic hypotension of a fixed combination of D-camphor and an extract from fresh Crataegus Berries and the contribution of the single components. Phytomedicine 2003; 10(Suppl.IV):61-67.
  • 39) Belz GG. Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology. Br J Clin Pharm 2003; 56:3-10. (Original-Artikel; PDF)
  • 40) Belz GG., Mohr-Kahaly S. Kakao und dunkle Schokolade zur kardiovaskulären Prävention? Dtsch Med Wochenschr. 2011; 136:2657-63.
  • 41) Eichhorn A, Lochner S, Belz GG. Vitamin D zur Prävention von Erkrankungen? Dtsch. Med. Wochenschr. 2012; 137:906-912
  • 42 ) Worm N, Belz GG., Stein-Hammer C. Moderater Weingenuss und Prävention der koronaren Herzkrankheit. Die Entwicklung der Evidenz. Dtsch. Med. Wochenschr. 2013; 138:2653-2657.
  • 43 ) Loew D, Belz GG. Acetylsalicylic acid (ASA) - How much, how often, and when? A clinical-pharmacological perspective. Int J Clin Pharmacol Ther. 2016; 54:634-9.

<    1 2 3